Before treatment planning, fertility testing checks ovarian response, ovulation, sperm function, the uterus, fallopian tubes, and health conditions that could affect pregnancy. You will be able to prepare for each test, understand when it is timed, and identify how clinicians combine results instead of treating one abnormal number as a diagnosis.
Key takeaways
- Test both partners early, including semen analysis.
- Schedule hormone tests according to the menstrual-cycle day.
- Use ultrasound, semen, and tubal tests to answer different questions.
- Review medical, infection, and genetic results before choosing treatment.
What happens during the first fertility evaluation?
The first fertility evaluation examines both partners at the same time, combining a medical history, physical examination, and targeted testing. This avoids completing an extensive female-factor work-up before checking sperm.
The clinician asks about age, time trying to conceive, menstrual regularity, previous pregnancies or miscarriages, pelvic infections, abdominal or pelvic surgery, pelvic pain, medications, and prior fertility treatment.
The physical examination may include blood pressure, body weight, signs of hormonal disorders, and a pelvic examination when clinically indicated. Timing depends on the planned treatment, symptoms, menstrual pattern, and previous results.
Prepare these items before the appointment:
- Bring previous reports, including ultrasound reports, semen analyses, operation notes, medication lists, and pregnancy records, so the clinic does not repeat testing unnecessarily.
- Complete your medication disclosure: mention hormonal contraception, supplements, steroids, testosterone, and medicines for thyroid disease or high prolactin because they can alter results.
- Ask whether each blood test requires fasting. Many reproductive hormone tests do not, while another test ordered during the same visit may require several hours without food. Follow the clinic’s instructions rather than fasting automatically.
| Evaluation component | What it examines | Why it matters |
|---|---|---|
| Medical history | Symptoms, reproductive history, treatment history, and medicines | Identifies likely causes and sets testing priorities |
| Physical examination | Blood pressure, weight, hormonal signs, and pelvic findings | Detects findings that change diagnosis or treatment |
| Testing for both partners | Sperm results and female reproductive findings | Prevents delayed recognition of male-factor infertility |
Which hormone and ovarian-reserve tests are timed to the cycle?
Ovarian-reserve tests estimate the number of recruitable follicles and the likely response to injectable gonadotropins; they do not measure egg quality or predict pregnancy on their own. Age remains a major determinant of egg chromosomal health.
| Test | Usual timing | What it helps assess |
|---|---|---|
| AMH | Most cycle days | Expected ovarian response; hormonal contraception and some ovarian conditions can affect interpretation |
| Antral follicle count | Early follicular phase, during transvaginal ultrasound | Visible recruitable follicles and expected stimulation response |
| FSH and estradiol | Blood drawn on cycle days 2–4 | Baseline ovarian function, interpreted together rather than in isolation |
| Luteinizing hormone | Timing depends on the clinical question | Ovulatory patterns and selected cycle disturbances |
| Progesterone | After ovulation, often about seven days before the expected next period | Whether ovulation likely occurred |
| TSH | Any cycle day | Thyroid assessment relevant to fertility and pregnancy planning |
| Prolactin | Any cycle day when indicated | Possible hyperprolactinemia, especially with galactorrhea, infrequent periods, or absent periods |
A low AMH or antral follicle count points to a smaller stimulation response, not impossible pregnancy. A high AMH does not guarantee good egg quality or a live birth, and neither test reliably predicts natural conception alone. Tell the clinician about hormonal contraception and ovarian conditions before testing, because both can change interpretation.
Ask which cycle day applies to each test rather than scheduling every blood draw on day 2.
How do ultrasound, semen analysis, and tubal tests add different information?
A pelvic ultrasound, semen analysis, and tubal test examine different parts of fertility: reproductive anatomy, sperm function, and whether the tubes are open.
| Test | What it measures | Key limitations |
|---|---|---|
| Pelvic ultrasound | Uterus, ovaries, antral follicle count, cysts, fibroids, endometrial changes, and clues of adenomyosis | A normal scan does not exclude adhesions, subtle endometriosis, or every uterine-cavity lesion |
| Semen analysis | Ejaculate volume, sperm concentration, total sperm number, total and progressive motility, morphology, and round cells | One abnormal result needs confirmation because values vary between ejaculates |
| Tubal testing | Whether contrast passes through the fallopian tubes and outlines the uterine cavity | It is more important before ovulation induction or IUI than before IVF |
The 2021 WHO reference values are about 1.4 mL volume, 16 million sperm per mL concentration, 39 million sperm per ejaculate, 42% total motility, 30% progressive motility, and 4% normal morphology. These are reference limits, not a fertile-versus-infertile boundary. Round cells can indicate inflammation or immature germ cells.
Before collection, abstain from ejaculation for two to seven days and collect the complete sample exactly as instructed. Repeat an abnormal analysis.
Hysterosalpingography, or HSG, uses X-ray contrast; HyCoSy uses ultrasound contrast; laparoscopy directly assesses the pelvis. IVF bypasses the tubes, but a communicating hydrosalpinx can reduce implantation, so clinicians base testing and treatment on symptoms, surgery, infection history, and the planned treatment. The uterine cavity still needs appropriate assessment.
Which blood, infection, and genetic tests are needed before treatment?
Before ovarian stimulation, the clinic confirms pregnancy status and orders infection tests and pre-treatment blood tests based on local rules, your treatment type, and your medical history. The panel is not identical for everyone.
| Test group | What it checks | When it applies |
|---|---|---|
| HIV, hepatitis B, and hepatitis C | Infectious-disease status before treatment | Required by clinic policy or local regulation |
| Blood group | ABO and Rh blood type | When relevant to pregnancy or treatment planning |
| Rubella or varicella immunity | Protection against infections that affect pregnancy | When vaccination or infection history is unclear |
| Pregnancy test | Whether pregnancy is already present | Before stimulation or treatment that could harm an existing pregnancy |
Give the clinic your vaccination history, previous infection results, surgery records, and complete medication list. Confirm fasting instructions; fasting is required only when specified, and another blood test at the same visit might change the instruction.
Genetic-carrier screening is separate from embryo genetic testing. It checks prospective parents for recessive or X-linked conditions, including when both people are healthy. A finding can lead to genetic counseling and discussion of prenatal diagnosis, donor gametes, or embryo testing in selected situations.
More tests do not automatically produce a more accurate fertility assessment. Routine endometrial-receptivity assays, broad immune panels, natural-killer-cell testing, and thrombophilia panels are not universally validated parts of the initial IVF work-up. Ask what decision each proposed test will change before paying for it or accepting treatment based on the result.
How are all fertility-test results turned into a treatment plan?
A treatment plan comes from the complete pattern, not a single test: your age, cycle history, ovarian reserve, ovulation, ultrasound findings, sperm results, medical conditions, and duration of infertility. One AMH value cannot diagnose infertility, just as one sperm result or ultrasound finding cannot explain every case.
Repeat semen analysis helps distinguish persistent male-factor findings from an isolated variation.
| Finding | What it changes | What it does not prove |
|---|---|---|
| Low AMH or AFC | Earlier planning or stimulation designed to avoid an unusually low response | It does not measure egg quality or make pregnancy impossible |
| High AMH or AFC | Safer gonadotropin dosing when an unusually high response is likely | It does not guarantee good egg quality or a live birth |
| Abnormal semen analysis | Repeat testing and possible male-factor treatment planning | One result does not establish a persistent problem |
| HSG, HyCoSy, or laparoscopy showing communicating hydrosalpinx | Treatment before embryo transfer may be considered because hydrosalpinx can reduce implantation and pregnancy rates | Tubal testing is more directly important before ovulation induction or IUI |
| Hysteroscopy finding a cavity lesion | Direct assessment and sometimes treatment of polyps or submucosal fibroids | It is not a substitute for tubal-patency testing |
Hysteroscopy directly views the uterine cavity; HSG uses X-ray contrast, and HyCoSy uses ultrasound contrast. Your clinic should explain which findings matter now, which need confirmation, and which tests are unnecessary.
At Deshmukh Maternity Hospital, ask for a written testing and decision timeline that connects your reports with individualized fertility, gynecological, and high-risk pregnancy care in Pune.
Related service
IVF Treatment What Is IVF? In Vitro Fertilization (IVF) is a groundbreaking fertility treatment that offers hope to individuals and couples facing infertility. View service → |
Frequently asked questions
What happens during the first fertility evaluation?
The evaluation covers both partners through medical history, physical examination, and targeted tests, including an early semen analysis.
Which fertility tests are timed to the menstrual cycle?
Follicle-stimulating hormone, luteinizing hormone, estradiol, and antral follicle count are commonly assessed at the start of the cycle. Progesterone is measured after ovulation to assess whether ovulation occurred.
How do ultrasound, semen analysis, and tubal tests provide different information?
Ultrasound assesses the uterus, ovaries, follicles, and antral follicle count. Semen analysis measures sperm concentration, movement, and shape. Tubal tests assess whether the fallopian tubes are open.
Which tests are done before assisted reproductive treatment?
Clinicians review blood counts, blood group, thyroid function, infection screening, and genetic tests selected according to medical history, family history, and treatment plans.
How are fertility-test results used to create a treatment plan?
The clinician combines both partners’ results with age, treatment history, duration of infertility, and pregnancy goals to decide whether to consider timed intercourse, IUI, IVF, or further evaluation.
